What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.
- DOI
- 10.12688/wellcomeopenres.26466.2
- Published
- 2026
- Container
- Wellcome open research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.12688/wellcomeopenres.26466.2,
title = {What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.},
author = {Martyn E and Carter J and Barlow M and Olcott F and Ghosh I and Waddilove E and Arenas-Pinto A and Gilson R and Flanagan S and Venter WF and Manne-Goehler J and Hargreaves S and Tsochatizis E and MacDonald D and Matthews PC},
year = {2026},
journal = {Wellcome open research},
doi = {10.12688/wellcomeopenres.26466.2},
url = {https://doi.org/10.12688/wellcomeopenres.26466.2}
}RIS
TY - JOUR TI - What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol. AU - Martyn E AU - Carter J AU - Barlow M AU - Olcott F AU - Ghosh I AU - Waddilove E AU - Arenas-Pinto A AU - Gilson R AU - Flanagan S AU - Venter WF AU - Manne-Goehler J AU - Hargreaves S AU - Tsochatizis E AU - MacDonald D AU - Matthews PC PY - 2026 JO - Wellcome open research DO - 10.12688/wellcomeopenres.26466.2 UR - https://doi.org/10.12688/wellcomeopenres.26466.2 ER -
APA
E, M., J, C., M, B., F, O., I, G., E, W., A, A., R, G., S, F., WF, V., J, M., S, H., E, T., D, M., & PC, M. (2026). What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.. Wellcome open research. https://doi.org/10.12688/wellcomeopenres.26466.2
Source records
- pubmed · retrieved 2026-09-25T09:07:37.022Z